Sérový noradrenalín a komorová tachykardia
[Serum noradrenaline and ventricular tachycardia]
Jazyk slovenština Země Česko Médium print
Typ dokumentu anglický abstrakt, časopisecké články
PubMed
10422489
- MeSH
- biologické markery krev MeSH
- kardiostimulace umělá MeSH
- komorová tachykardie krev komplikace MeSH
- lidé MeSH
- náhlá srdeční smrt etiologie MeSH
- noradrenalin krev MeSH
- rizikové faktory MeSH
- senioři MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- anglický abstrakt MeSH
- časopisecké články MeSH
- Názvy látek
- biologické markery MeSH
- noradrenalin MeSH
Sudden cardiac death is in the majority of cases due to ventricular tachycardia (VT) developing into ventricular flutter or ventricular fibrillation. It is therefore very important to detect patients with the risk of sudden cardiac death because their mortality depends on the treatment selected. The authors tried to shift the problem of sudden cardiac death into the sphere of cardioendocrinology. They examined the serum levels of norepinephrine (NE) in 17 patients. They collected simultaneously blood samples from the left cubital vein and right atrium after 5 minutes stimulation of the apex of the right ventricle, the frequency of stimulation being 100/min. In ten patients during electrophysiological examination VT was induced (four patients had persisting VT). The authors found a declining NE serum value in the periphery and rising intracardial NE serum level after ventricular stimulation. These differences were statistically significant in patients with VT but not in patients without VT.